CEO Communication 2018

Another fantastic year 

Last year we celebrated our one-year anniversary as part of Mayoly Spindler Laboratories, and now Kibion is successfully integrated in the group. Not only am I proud and thankful that Mayoly Spindler continues to invest in Kibion and supports our goal to further contribute to the gastro healthcare worldwide, but I am also proud of what we at Kibion accomplished in 2017.

Kibion reached records sales again and the company continued to successfully grow its markets shares on key markets, and the new instrument, Kibion® Dynamic, was a key growth driver. The sales of Kibion® Dynamic, doubled in 2017 vs last year which is a proof that the innovative instrument with its new features is appreciated by the customers and brings substantial value for health care professionals.

We aim to further build trust by continuing to deliver quality products. To accomplish this, we continuously invest in competence and resources internally, with extra focus on Quality & Regulatory Affairs. Kibion is a ISO 13485 certified company, which is something that we value highly.

Continuous learning and improvement
We always try to do things better. Even though our instruments offer superior quality in design and performance, we focus on and invest in our service and support functions. In addition, we strive to further develop our products to meet the customers’ specific requirements. One example is the continuous upgrading of our instruments’ software solutions to meet the customers’ needs. Another example is our efforts to find opportunities to further improve the usability of Kibion’s innovative instruments and our services.

Working for a better gastro healthcare
Kibion already has representation in over 60 countries, mainly in the Middle East and the EU, and we have the goals and strategy in place for additional global expansion and growth. Last year Kibion added Algeria, Morocco and Vietnam as key markets, and our ambition is to expand into new exciting geographical markets moving forward.

As a leading company in the market, we are committed to live our vision “To be first in mind, first in choice”. Our ambition is to bring value – not only to our distributors by providing the end users with our instruments and tests – but also to the many patients who benefit from our user-friendly breath tests. This is important to us, since we are working for a better gastro healthcare worldwide.

Welcome to contact us and we will be happy to tell you more about our products and services.

Petter Bäckgren, President and CEO, Kibion AB Kibion is part of Laboratoires Mayoly Spindler www.mayoly-spindler.fr